Clinical Trial Update: Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical evaluation of SB-497115-GR for chronic immune thrombocytopenia. The trial has completed and its results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• SB-497115-GR

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chronic Idiopathic Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Idiopathic | Phase 3 | Status: COMPLETED | Results posted: 2009-12-31